| pubmed-article:6434321 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:6434321 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:6434321 | lifeskim:mentions | umls-concept:C0342895 | lld:lifeskim |
| pubmed-article:6434321 | lifeskim:mentions | umls-concept:C1158917 | lld:lifeskim |
| pubmed-article:6434321 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:6434321 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:6434321 | pubmed:dateCreated | 1984-11-20 | lld:pubmed |
| pubmed-article:6434321 | pubmed:abstractText | In the rare familial disorder fish-eye disease, hypertriglyceridaemia is associated with elevated levels of very-low-density lipoprotein (VLDL) and enrichment of low-density lipoprotein (LDL) with triglyceride. The kinetic basis of the dyslipoproteinaemia was investigated by studying the metabolism of the apolipoprotein-B moeity of VLDL, intermediate-density lipoprotein (IDL) and LDL in a 68-year-old woman with this condition. The major kinetic abnormality was a pronounced reduction in the rate of fractional conversion of VLDL-B to IDL-B and of IDL-B to LDL-B, suggesting that the dyslipoproteinaemia represents accumulation in plasma of partly degraded products of VLDL metabolism. This kinetic disorder has features in common with type-III hyperlipoproteinaemia. In studies in vitro no defect in the enzyme, activator or substrate components of the lipoprotein lipase or hepatic lipase systems was observed. | lld:pubmed |
| pubmed-article:6434321 | pubmed:language | eng | lld:pubmed |
| pubmed-article:6434321 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6434321 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:6434321 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6434321 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6434321 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6434321 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6434321 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6434321 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6434321 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6434321 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:6434321 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:6434321 | pubmed:issn | 0014-2972 | lld:pubmed |
| pubmed-article:6434321 | pubmed:author | pubmed-author:MillerN ENE | lld:pubmed |
| pubmed-article:6434321 | pubmed:author | pubmed-author:LewisBB | lld:pubmed |
| pubmed-article:6434321 | pubmed:author | pubmed-author:CarlsonL ALA | lld:pubmed |
| pubmed-article:6434321 | pubmed:author | pubmed-author:RaoSS | lld:pubmed |
| pubmed-article:6434321 | pubmed:author | pubmed-author:TurnerP RPR | lld:pubmed |
| pubmed-article:6434321 | pubmed:author | pubmed-author:CorteseCC | lld:pubmed |
| pubmed-article:6434321 | pubmed:author | pubmed-author:MarenahC BCB | lld:pubmed |
| pubmed-article:6434321 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:6434321 | pubmed:volume | 14 | lld:pubmed |
| pubmed-article:6434321 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:6434321 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:6434321 | pubmed:pagination | 273-7 | lld:pubmed |
| pubmed-article:6434321 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:6434321 | pubmed:meshHeading | pubmed-meshheading:6434321-... | lld:pubmed |
| pubmed-article:6434321 | pubmed:meshHeading | pubmed-meshheading:6434321-... | lld:pubmed |
| pubmed-article:6434321 | pubmed:meshHeading | pubmed-meshheading:6434321-... | lld:pubmed |
| pubmed-article:6434321 | pubmed:meshHeading | pubmed-meshheading:6434321-... | lld:pubmed |
| pubmed-article:6434321 | pubmed:meshHeading | pubmed-meshheading:6434321-... | lld:pubmed |
| pubmed-article:6434321 | pubmed:meshHeading | pubmed-meshheading:6434321-... | lld:pubmed |
| pubmed-article:6434321 | pubmed:meshHeading | pubmed-meshheading:6434321-... | lld:pubmed |
| pubmed-article:6434321 | pubmed:meshHeading | pubmed-meshheading:6434321-... | lld:pubmed |
| pubmed-article:6434321 | pubmed:meshHeading | pubmed-meshheading:6434321-... | lld:pubmed |
| pubmed-article:6434321 | pubmed:meshHeading | pubmed-meshheading:6434321-... | lld:pubmed |
| pubmed-article:6434321 | pubmed:meshHeading | pubmed-meshheading:6434321-... | lld:pubmed |
| pubmed-article:6434321 | pubmed:meshHeading | pubmed-meshheading:6434321-... | lld:pubmed |
| pubmed-article:6434321 | pubmed:meshHeading | pubmed-meshheading:6434321-... | lld:pubmed |
| pubmed-article:6434321 | pubmed:meshHeading | pubmed-meshheading:6434321-... | lld:pubmed |
| pubmed-article:6434321 | pubmed:year | 1984 | lld:pubmed |
| pubmed-article:6434321 | pubmed:articleTitle | Studies of lipoprotein metabolism in a patient with fish-eye disease. | lld:pubmed |
| pubmed-article:6434321 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:6434321 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6434321 | lld:pubmed |
